Anti-CD123 chimeric antigen receptor redirected T cells for relapsed B-cell acute lymphoblastic leukemia

      Figure thumbnail fx1
      Figure 1CD123 expression on ALL blasts at baseline and at CD19-ve relapse.
      Figure thumbnail fx2
      Figure 2AComparison of in vitro anti-tumor activity of CART123 and CART19.
      Figure thumbnail fx3
      Figure 2BIn vitro anti-tumor activity of CART19 and CART123 against ALL.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Cytotherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect